Clinical Pipeline


CordIn™ for Rare Genetic Diseases

CordIn is Gamida Cell’s curative treatment for rare genetic diseases, including blood diseases such as sickle cell disease (SCD) and thalassemia, bone marrow failure syndromes such as aplastic anemia, genetic metabolic diseases.

Data to date has been encouraging, showing successful and rapid engraftment and cure of disease symptoms in these hard to engraft patients.  Thus, the product appears to overcome the engraftment barriers of umbilical cord blood and has the potential to increase access to curative transplantation for SCD.  Clinical studies are ongoing.